First Project: Oversee Construction of Company Headquarters
CEDAR RAPIDS, Iowa, August 24, 2006 -- Embria(tm) Health Sciences, a raw material manufacturer of science-backed natural ingredients for the human nutrition market, appointed Mark Joyner to the position of director of operations. Joyner will be responsible for procuring raw material to be used in existing products, scheduling production, maintaining quality management system, ensuring environmental regulatory compliance and supporting employee safety. Joyner's first endeavor will be overseeing the construction of the new Embria headquarter building in Ankeny, Iowa to ensure that the project is completed on time and within budget.
Previously, Joyner was an integral part of Embria's parent company, Diamond V Mills, for more than 30 years. Since starting on with Diamond V in 1973, Joyner has held a number of positions, including:
foreman, assistant plant manager, plant manager, manufacturing and regulatory affairs manager and operations manager. Joyner holds a bachelor's degree in computer science and business administration from Mount Mercy College in Cedar Rapids, Iowa. He has completed executive education courses at the University of Wisconsin and is a member of the American Management Association (AMA).
"For more than three decades we have seen the high levels of dedication and commitment Mark has put into his work at Diamond V," said Paul Faganel, president, Embria Health Sciences. "The management skills he has so expertly displayed at Diamond V will be a definite asset to the company values of Embria."
Embria Health Sciences, www.embriahealth.com, combines science and nature to bring high-quality, research-based natural ingredients to the global human nutrition market. Embria's key products are manufactured using a proprietary technology, which produces vital metabolites that deliver nutritional benefits and support increased bioavailability. Embria holds Nutrition Business Journal's 2005 product merit award for its selenium ingredient, eXselen(tm) and recently launched EpiCor(tm), the first ingredient in a new category of the immune health market.